Medicinal cannabis framework ‘not fit for purpose’

Stakeholders flag safety concerns over “outdated, under-regulated and inadequate” unapproved medicinal cannabis framework  Submissions to the Therapeutic Goods Administration’s (TGA’s) consultation: reviewing the safety and regulatory oversight of unapproved medicinal cannabis products say the current model needs reform.  Stakeholders have noted the current Special Access Scheme (SAS) and Authorised Prescriber pathways are “not fit-for-purpose and not appropriate to the potential safety and